| Peer-Reviewed

Nanomedicine for Treatment of Cancer

Received: 27 April 2016     Accepted: 3 June 2016     Published: 17 June 2016
Views:       Downloads:
Abstract

Published in Pharmaceutical Science and Technology (Volume 1, Issue 1)
DOI 10.11648/j.pst.20170101.12
Page(s) 4-5
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2016. Published by Science Publishing Group

Keywords

References
[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA: A Cancer Journal for Clinicians, 2016; 66: 7-30.
[2] Livingston RB. Single agents in cancer chemotherapy. Springer Science & Business Media 2012.
[3] Vanneman M, Dranoff G. Combining immunotherapy and targeted therapies in cancer treatment. Nature Reviews Cancer, 2012; 12: 237-251.
[4] Plenderleith IH. Treating the treatment: toxicity of cancer chemotherapy. Canadian Family Physician, 1990; 36: 1827.
[5] Bae YH, Park K. Targeted drug delivery to tumors: myths, reality and possibility. Journal of Controlled Release, 2011; 153: 198.
[6] Lee S-H, Roichman Y, Yi G-R, Kim S-H, Yang S-M, van Blaaderen A, van Oostrum P, Grier DG. Characterizing and tracking single colloidal particles with video holographic microscopy. Optics Express, 2007; 15: 18275-18282.
[7] Wang C, Zhong X, Ruffner DB, Stutt A, Philips LA, Ward MD, Grier DG. Holographic characterization of protein aggregates. Journal of pharmaceutical sciences, 2016; 105: 1074-1085.
[8] Fenske DB, Chonn A, Cullis PR. Liposomal nanomedicines: an emerging field. Toxicologic pathology, 2008; 36: 21-29.
[9] Kang C, Sun Y, Wang M, Cheng X. Nanosized Camptothecin Conjugates for Single and Combined Drug Delivery. European Journal of BioMedical Research, 2016; 2: 8-14.
[10] Kim SH, Kaplan JA, Sun Y, Shieh A, Sun HL, Croce CM, Grinstaff MW, Parquette JR. The Self‐Assembly of Anticancer Camptothecin–Dipeptide Nanotubes: A Minimalistic and High Drug Loading Approach to Increased Efficacy. Chemistry–A European Journal, 2015; 21: 101-105.
[11] Sun Y, Kaplan JA, Shieh A, Sun H-L, Croce CM, Grinstaff MW, Parquette JR. Self-assembly of a 5-fluorouracil-dipeptide hydrogel. Chemical Communications, 2016; 52: 5254-5257.
[12] Green M, Manikhas G, Orlov S, Afanasyev B, Makhson A, Bhar P, Hawkins M. Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer. Annals of Oncology, 2006; 17: 1263-1268.
[13] Linkov I, Satterstrom FK, Corey LM. Nanotoxicology and nanomedicine: making hard decisions. Nanomedicine: Nanotechnology, Biology and Medicine, 2008; 4: 167-171.
Cite This Article
  • APA Style

    Yuan Sun, Xiao Zhong, Chen Kang. (2016). Nanomedicine for Treatment of Cancer. Pharmaceutical Science and Technology, 1(1), 4-5. https://doi.org/10.11648/j.pst.20170101.12

    Copy | Download

    ACS Style

    Yuan Sun; Xiao Zhong; Chen Kang. Nanomedicine for Treatment of Cancer. Pharm. Sci. Technol. 2016, 1(1), 4-5. doi: 10.11648/j.pst.20170101.12

    Copy | Download

    AMA Style

    Yuan Sun, Xiao Zhong, Chen Kang. Nanomedicine for Treatment of Cancer. Pharm Sci Technol. 2016;1(1):4-5. doi: 10.11648/j.pst.20170101.12

    Copy | Download

  • @article{10.11648/j.pst.20170101.12,
      author = {Yuan Sun and Xiao Zhong and Chen Kang},
      title = {Nanomedicine for Treatment of Cancer},
      journal = {Pharmaceutical Science and Technology},
      volume = {1},
      number = {1},
      pages = {4-5},
      doi = {10.11648/j.pst.20170101.12},
      url = {https://doi.org/10.11648/j.pst.20170101.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.pst.20170101.12},
      abstract = {},
     year = {2016}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Nanomedicine for Treatment of Cancer
    AU  - Yuan Sun
    AU  - Xiao Zhong
    AU  - Chen Kang
    Y1  - 2016/06/17
    PY  - 2016
    N1  - https://doi.org/10.11648/j.pst.20170101.12
    DO  - 10.11648/j.pst.20170101.12
    T2  - Pharmaceutical Science and Technology
    JF  - Pharmaceutical Science and Technology
    JO  - Pharmaceutical Science and Technology
    SP  - 4
    EP  - 5
    PB  - Science Publishing Group
    SN  - 2640-4540
    UR  - https://doi.org/10.11648/j.pst.20170101.12
    AB  - 
    VL  - 1
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, USA

  • Molecular Design Institute, Department of Chemistry, New York University, NY, USA

  • Division of Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA

  • Sections